{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:46:51Z","timestamp":1767134811236,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":36,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd002829.pub3","type":"reference-entry","created":{"date-parts":[[2005,1,15]],"date-time":"2005-01-15T22:16:46Z","timestamp":1105827406000},"source":"Crossref","is-referenced-by-count":9,"title":["Antioxidant treatment for amyotrophic lateral sclerosis \/ motor neuron disease"],"prefix":"10.1002","author":[{"given":"RW","family":"Orrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RJM","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,1,24]]},"reference":[{"key":"10.1002\/14651858.CD002829.pub3-BIB1|cit1","first-page":"325","article-title":"Glutathione peroxidase in amyotrophic lateral sclerosis: the effects of selenium supplementation","volume":"17","author":"Apolstolski","year":"1998","journal-title":"Journal of Environmental Pathology, Toxicology and Oncology"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/146608201300079364","article-title":"A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis","volume":"2","author":"Desnuelle","year":"2001","journal-title":"Amyotrophic Lateral Sclerosis & other motor neuron disorders"},{"key":"10.1002\/14651858.CD002829.pub3-BIB3|cit3","first-page":"A127","article-title":"Combination antioxidant therapy in amyotrophic lateral sclerosis","volume":"48","author":"Ellis","year":"1997","journal-title":"Neurology"},{"issue":"Supplementum","key":"10.1002\/14651858.CD002829.pub3-BIB4|cit4","first-page":"237","article-title":"Double blind cross over trial with deprenyl in amyotrophic lateral sclerosis","volume":"41","author":"Jossan","year":"1994","journal-title":"Journal of Neural Transmission"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archneur.55.1.93","article-title":"Selegiline is ineffective in a collaborative double-blind, placebo-controlled trial for treatment of amyotrophic lateral sclerosis","volume":"55","author":"Lange","year":"1998","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD002829.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archneur.1995.00540300031009","article-title":"Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis","volume":"52","author":"Louwerse","year":"1995","journal-title":"Archives of Neurology"},{"issue":"8878","key":"10.1002\/14651858.CD002829.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92906-A","article-title":"Cu\/Zn superoxide dismutase free radicals, and motoneuron disease [Letter]","volume":"342","author":"Mitchell","year":"1993","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD002829.pub3-BIB8|cit8","first-page":"233","article-title":"Serial studies of free radical and antioxidant activity in motor neurone disease and the effect of selegiline [letter]","volume":"4","author":"Mitchell","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1002\/14651858.CD002829.pub3-BIB9|cit9","first-page":"297","article-title":"Indices of free radical and antioxidant activity in amyotrophic lateral sclerosis","volume-title":"ALS - from Charcot to the present and into the future","author":"Mitchell","year":"1994"},{"key":"10.1002\/14651858.CD002829.pub3-BIB10|cit10","first-page":"223","article-title":"A controlled trial of combination of methionine and antioxidants in ALS patients","volume":"20","author":"Stevic","year":"2001","journal-title":"Jugoslavenska Medicinska Biokemija"},{"key":"10.1002\/14651858.CD002829.pub3-BIB11|cit11","series-title":"Proceedings ALS\/MND International Alliance Meeting, Munich, Germany","article-title":"A controlled trial of combination of methionine and antioxidants in amyotrophic lateral sclerosis","author":"Stevic","year":"1998"},{"issue":"6","key":"10.1002\/14651858.CD002829.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02341783","article-title":"Reduced glutathione in amyotrophic lateral sclerosis: an open, crossover, randomized trial","volume":"19","author":"Chio","year":"1998","journal-title":"Italian Journal of Neurological Science"},{"issue":"2","key":"10.1002\/14651858.CD002829.pub3-BIB14|cit13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jama.209.2.257","article-title":"Therapeutic trial in amyotrophic lateral sclerosis","volume":"209","author":"Dorman","year":"1969","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002829.pub3-BIB13|cit14","first-page":"199","article-title":"Metabolic studies and therapeutic trials in amyotrophic lateral sclerosis","volume-title":"Motor neuron diseases","author":"Engel","year":"1969"},{"issue":"Suppl","key":"10.1002\/14651858.CD002829.pub3-BIB16|cit15","first-page":"25","article-title":"A randomised trial of antioxidative therapy in amyotrophic lateral sclerosis","volume":"243","author":"Janik","year":"1996","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD002829.pub3-BIB15|cit16","first-page":"101","article-title":"The effect of selegiline and vitamin E in the treatment of ALS: an open randomized clinical trial [Polish]","volume":"Supplement 1","author":"Kwiecinski","year":"2001","journal-title":"Neurologia i Neurochirurgia Polska"},{"issue":"4","key":"10.1002\/14651858.CD002829.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00863772","article-title":"An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis","volume":"241","author":"Mazzini","year":"1994","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD002829.pub3-BIB18|cit18","first-page":"183","article-title":"Nutritional supplements in amyotrophic lateral sclerosis","volume":"209","author":"Norris","year":"1987","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1002\/14651858.CD002829.pub3-BIB19|cit19","first-page":"189","article-title":"Pancreatic dysfunction in amyotrophic lateral sclerosis","volume-title":"Motor neuron diseases","author":"Quick","year":"1969"},{"issue":"XLVIII","key":"10.1002\/14651858.CD002829.pub3-BIB20|cit20","first-page":"821","article-title":"Assessment of the efficacy of treatment with pimozide in patients with amyotrophic lateral sclerosis","volume":"T32","author":"Szczudilk","year":"1998","journal-title":"Neurologia i Neurochirurgia Polska"},{"key":"10.1002\/14651858.CD002829.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-510X(96)00071-8","article-title":"Survival in patients with amyotrophic lateral sclerosis treated with an array of antioxidants","volume":"39 Suppl","author":"Vyth","year":"1996","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD002829.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00000441-194012000-00005","article-title":"The treatment of amyotrophic lateral sclerosis with vitamin E (tocopherols)","volume":"200","author":"Wechsler","year":"1940","journal-title":"American Journal of Medical Science"},{"issue":"6438","key":"10.1002\/14651858.CD002829.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/364584a0","article-title":"ALS, SOD and peroxynitrite","volume":"364","author":"Beckman","year":"1993","journal-title":"Nature"},{"key":"10.1002\/14651858.CD002829.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-4899-0209-2_33","article-title":"Oxidative stress plays a role in the pathogenesis of familial and sporadic amyotrophic lateral sclerosis","volume-title":"Neurodegenerative Diseases","author":"Bergeron","year":"1996"},{"key":"10.1002\/14651858.CD002829.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases\/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial \"Clinical limits of amyotrophic lateral sclerosis\" workshop contributors","volume":"124 Suppl","author":"Brooks","year":"1994","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD002829.pub3-BIB26|cit26","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511663307","volume-title":"Amyotrophic lateral sclerosis: a synthesis of research and clinical practice","author":"Eisen","year":"1998"},{"issue":"2","key":"10.1002\/14651858.CD002829.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410390203","article-title":"Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis","volume":"39","author":"Gurney","year":"1996","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD002829.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","article-title":"Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment","volume":"18","author":"Halliwell","year":"2001","journal-title":"Drugs and Aging"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3940(94)90213-5","article-title":"Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease","volume":"182","author":"Ince","year":"1994","journal-title":"Neuroscience Letters"},{"key":"10.1002\/14651858.CD002829.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0404.1989.tb01787.x","article-title":"The pharmacology of selegiline ((-)deprenyl). New aspects","volume":"126","author":"Knoll","year":"1989","journal-title":"Acta Neurologica Scandinavica. Supplementum"},{"issue":"9013","key":"10.1002\/14651858.CD002829.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"A dose-ranging study of riluzole in amyotrophic lateral sclerosis","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD002829.pub3-BIB32|cit32","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND) (Cochrane review)","author":"Miller","year":"2004","journal-title":"The Cochrane Library"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0733-8619(18)30934-4","article-title":"Heavy metals and trace elements in amyotrophic lateral sclerosis","volume":"5","author":"Mitchell","year":"1987","journal-title":"Neurology Clinics"},{"key":"10.1002\/14651858.CD002829.pub3-BIB34|cit34","first-page":"5","article-title":"Antioxidant therapy in ALS","volume":"1 Suppl 4","author":"Pioro","year":"2000","journal-title":"ALS and other motor neuron disorders"},{"issue":"6415","key":"10.1002\/14651858.CD002829.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in CuZn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"issue":"1","key":"10.1002\/14651858.CD002829.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/011542659501000119","article-title":"Role of antioxidants in health maintenance","volume":"10","author":"Sardesai","year":"1995","journal-title":"Nutrition in Clinical Practice"}],"updated-by":[{"DOI":"10.1002\/14651858.cd002829.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,1,24]],"date-time":"2007-01-24T00:00:00Z","timestamp":1169596800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD002829.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:13:00Z","timestamp":1628529180000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002829.pub3"}},"subtitle":[],"editor":[{"given":"Richard","family":"Orrell","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,1,24]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002829.pub3","relation":{},"subject":[],"published":{"date-parts":[[2005,1,24]]}}}